AGP Picks
View all

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on August 17, 2026

Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
La Fenice Centre Brings Independently Published Frequency Therapy Research to Thornbury
Functional Brands Announces Second Quarter 2026 Financial Results
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Cooper Clinic Introduces Digital Nutrition Platform
Sinusitis Affects 9 in 10 Singaporeans, but Chronic Cases May Require Surgery
MD Logic Health Unveils Innovative Daily Multi-Fiber Supplement Featuring Clinically-Proven Solnul Resistant Potato Starch
From Marathons to Long-Haul Flights: The Hydration Science Shaping Electrolyte Choices
Neurovascular Devices Market to Grow from USD 4.64 Billion in 2025 to USD 7.22 Billion by 2030, at a CAGR of 9.3%– MarketsandMarkets™
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
Zealand Pharma - Transactions related to share buy-back program (week 33, 2026)
Shuwen Biotech Announces PRE-CERCA International Study Evaluating CercaTest RED™ for Prediction of Preeclampsia
DentSpa Earns GHA Certification for Its International Patient Experience
Bridging Healthcare and Football: How Ballipinar Dental Clinic is Scoring Big in the UK Market
Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Gelatin Market to Grow from USD 4.59 Billion in 2026 to USD 6.43 Billion by 2031, at a CAGR of 7.0% — MarketsandMarkets™
Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment
Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies
NTHI’s Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia Healthcare Industry Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.